In this week's Medical Device Reading List, Medtronic is rocking and rolling with a positive clinical study result and FDA approval of their Guardian Connect CGM while Johnson & Johnson take steps away from the CGM with a possible divestiture of their LifeScan business.
Johnson & Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc.
Press Release ($JNJ)
Medtronic's Positive Study Results May Boost CSH Business
Zacks ($MDT)
Medtronic (MDT) Receives FDA Approval for Guardian Connect CGM System for People Living with Diabetes
Street Insider ($MDT)
Johnson & Johnson’s Ethicon loses $35m pelvic mesh lawsuit
Brad Perriello, Mass Device ($JNJ)
Johnson & Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc.
Press Release ($JNJ)
Medtronic's Positive Study Results May Boost CSH Business
Zacks ($MDT)
Medtronic (MDT) Receives FDA Approval for Guardian Connect CGM System for People Living with Diabetes
Street Insider ($MDT)
Johnson & Johnson’s Ethicon loses $35m pelvic mesh lawsuit
Brad Perriello, Mass Device ($JNJ)
RSS Feed
